Near-Infrared Spectroscopy for Blood Glucose Measurements
Completed
Conditions studied: Healthy
In brief
The purpose of this study is to evaluate the performance of a near-infrared transmission measurement in blood samples collected from healthy volunteers. We propose that NIR spectroscopic blood glucose measurements in healthy patients are as accurate as handheld glucometers and a Yellow Springs Instrument (YSI). We will also evaluate in vitro blood samples spiked with pharmacological interferents to test if the spectroscopic glucose measurement is affected by common medications.
Key facts
- Study ID
- NCT01168115
- Run by
- InLight Solutions
- People needed
- 50
- Starts
- 2008-01-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2010-07-22
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Males and females between the ages of 18 and 65
- Healthy
- Not currently pregnant
- Hematocrit >38%
You may not qualify if…
- Pregnancy (Self Reported)
- Females that have given birth 6 weeks prior (self reported)
- Anemia (hematocrit <38%) Hematocrit is checked via a capillary fingerstick and a blood hematocrit reader.
- Under the age of 18 or over the age of 65.
- Diagnosed with Type I or II Diabetes (Self-Reported).
- Donated blood (>25 mls) in the last 8 weeks
- Heart rate >100 beats per minute
- Weigh less than 110 lbs.
- Currently taking anticoagulants (ex: coumadin)
- Abnormal blood pressure (diastolic >90)
Where it is running
- InLight Solutions — Albuquerque, New Mexico, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.